On June 15th, the Judicial Panel on Multidistrict Litigation (JPML) issued a report on pending MDL dockets currently active in all U.S. District Courts. The document shows more than 200 lawsuits pending in the Eastern District of Kentucky for the drugs Onglyza and Kombiglyze XR—a…
In recent years, intravenous iron medication has skyrocketed in popularity in the United States as a means of treatment for those 4.5 million Americans who suffer from Iron Deficiency Anemia (IDA). IDA is caused by a shortage of iron and red blood cells in the…
Avanir Pharmaceuticals manufactures Nuedexta, a prescription drug medication approved by the Food and Drug Administration (FDA) to treat a rare condition—pseudobulbar affect (PBA)—where sufferers experience uncontrollable laughing and crying. Yet, a recent CNN investigation has found that doctors increasingly are prescribing the drug to dementia…
Mass tort cases continue to pile up for Johnson & Johnson (J&J) and their subsidiaries. So is the case with Risperdal, a treatment for bipolar disorder and schizophrenia that was first approved by the Food and Drug Administration (FDA) in 1993 and then became the…
Actemra (tocilizumab) is a drug used to treat moderate to severe rheumatoid arthritis (RA). RA affects over 1.5 million people in the U.S. and women are three times more likely than men to get this disease. RA is a progressive, systemic, autoimmune disease usually striking…
When Invokana was first approved by the Food and Drug Administration (FDA) in 2013, it commenced a new class of diabetes treatment. Specifically known as an SGLT2 inhibitor, canagliflozin—the trade name of Janssen Pharmaceuticals’ Invokana—was the first drug of its kind to be marketed in…
On October 11, 2016, homeopathic medicine manufacturer Hyland’s issued a public letter to parents everywhere. Beginning with “Dear Moms and Dads…” the corporate communication went on to say that they would no longer be distributing their line of homeopathic teething tablets and gels in the…
Earlier this month, Plaintiffs with current litigation against AstraZeneca and Bristol-Myers Squibb for injuries related to their SGLT2 diabetes drug, Farxiga, petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate their cases in the U.S. District Court of the Eastern District of Pennsylvania.…